Cholenergic Pharm Flashcards
Drugs that may be used to treat dry mouth (xerostima)
Pilocarpine, Cevimeline
*both are cholinomimetics, MAchR agonists
Drugs to treat fatigue in patient with myasthenia gravis
Pyridostigmine (most common), Neostigmine
*AChE inhibitor
Drugs to treat dyspnea in COPD
Ipratropium, Tiotropium (longer lasting)
*Inhaled MAChR (M3) antagonists
Mechanism of action for Varenicline
Partial agonist of a4B2 NAChR in the brain
Anticipated adverse effects of Varenicline
nasuea, behavior changes, agitation, depression, suicidal ideation, attempted and completed suicide
*if these occur, pt should discontinue it and contact doc
Physiologic effects of nicotine poisoning (activation of NAChRs) in the cardiac, pulmonary, renal and musculoskeletal systems
- Cardio: HTN and arrythmias
- Pulmonary: respiratory paralysis
- Renal: HTN?
- MSK: paralysis
Drugs to treat urinary incontinence
Oxybutynin (side effects), Darifenacin, Solifenacin, Tolterodine, Trospium (nonselective)
*MAChR (M3) antagonists
Expected side effects in patient treated with MAChR (M3) antagonists (Oxybutynin, Darifenacin, Solifenacin, Tolterodine) for urinary incontinence
Xerostima, dry eyes, dry mouth, dizziness, constipation, UTI
Drug to treat arrhythmia in patient who overdoses on diphenhydramine
Physostigmine
- centrally and peripherally as AChE inhibitor
- Diphenhydramine has anticholenergic properties
Ganglionic blocking drugs (Mecamylamine, NAChR antagonist) affect in anesthesia
Blocks autonomic outflow, parasympathetic activity normally dominates, so “sympathetic” end organ effects would be observed
CNS: sedation, tremor
Eye: cycloplegia, mydriasis
CV: vasodilation, hypotension, decreased contractility, tachycardia
GI: reduced secretions and inhibited motility
GU: urinary retention